• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Displaying 84-98 of 246 results

9 Objection: Patent Owners Objections to Evidence

Document IPR2017-01357, No. 9 Objection - Patent Owners Objections to Evidence (P.T.A.B. Dec. 15, 2017)

cite Cite Document

6 Preliminary Response: Patent Owner Preliminary Response

Document IPR2017-01357, No. 6 Preliminary Response - Patent Owner Preliminary Response (P.T.A.B. Sep. 5, 2017)

cite Cite Document

5 Mandatory Notice: Patent Owner Mandatory Notice

Document IPR2017-01357, No. 5 Mandatory Notice - Patent Owner Mandatory Notice (P.T.A.B. Jun. 9, 2017)

cite Cite Document

4 Power of Attorney: Power of Attorney

Document IPR2017-01357, No. 4 Power of Attorney - Power of Attorney (P.T.A.B. Jun. 9, 2017)

cite Cite Document

1 Power of Attorney: Petitioners Power of Attorney

Document IPR2017-01357, No. 1 Power of Attorney - Petitioners Power of Attorney (P.T.A.B. May. 19, 2017)

cite Cite Document

2307 Exhibit: EX2307 Winters

Document IPR2017-01357, No. 2307-81 Exhibit - EX2307 Winters (P.T.A.B. Jul. 5, 2018)

cite Cite Document

2302 Exhibit: EX2302 Wieland

Document IPR2017-01357, No. 2302-76 Exhibit - EX2302 Wieland (P.T.A.B. Jul. 5, 2018)

cite Cite Document

2204 Exhibit: EX2204 Fuller

Document IPR2017-01357, No. 2204-71 Exhibit - EX2204 Fuller (P.T.A.B. Jun. 19, 2018)

cite Cite Document

2203 Exhibit: EX2203 Markussen

Document IPR2017-01357, No. 2203-70 Exhibit - EX2203 Markussen (P.T.A.B. Jun. 19, 2018)

cite Cite Document

1046 Exhibit: Ex 1046 Sanchayita Ghose et al, pH Transitions in Ion Exchange Sys...

Document IPR2017-01357, No. 1046-59 Exhibit - Ex 1046 Sanchayita Ghose et al, pH Transitions in Ion Exchange Systems Role in the Development of a Cation Exchange Process for a Recombinant Prot...

cite Cite Document

1045 Exhibit: Ex 1045 Pete Gagnon Chapter 17 Polishing Methods for Monoclonal ...

Document IPR2017-01357, No. 1045-58 Exhibit - Ex 1045 Pete Gagnon Chapter 17 Polishing Methods for Monoclonal IgG Purification, in Process Scale Bioseparations for the Biopharmaceutical Industry...

cite Cite Document

1053 Exhibit: Ex 1053 Protocol for Citrate Buffer Conductivity Measurements prepa...

Document IPR2017-01357, No. 1053-66 Exhibit - Ex 1053 Protocol for Citrate Buffer Conductivity Measurements prepared by Todd M Przybycien on May 8, 2017 Protocol (P.T.A.B. May. 24, 2018)

cite Cite Document

1027 Exhibit: Ex 1027 Updated Formulas and Calculations prepared by Todd M Pry...

Document IPR2017-01357, No. 1027-41 Exhibit - Ex 1027 Updated Formulas and Calculations prepared by Todd M Pryzbycien in response to Dr Cramers Direct Testimony (P.T.A.B. May. 24, 2018)

cite Cite Document

1031 Exhibit: Ex 1031 Ghose et al, Binding Capacity Differences for Antibodies and...

Document IPR2017-01357, No. 1031-45 Exhibit - Ex 1031 Ghose et al, Binding Capacity Differences for Antibodies and Fc Fusion Proteins on Protein A Chromatographic Materials, Biotech Bioengg, 964 ...

cite Cite Document

1030 Exhibit: Ex 1030 Ghose et al, Antibody Variable Region Interactions with Prot...

Document IPR2017-01357, No. 1030-44 Exhibit - Ex 1030 Ghose et al, Antibody Variable Region Interactions with Protein AImplications for the Development of Generic Purification Processes,¿¿¿ Biotech, ...

cite Cite Document
<< 1 2 3 4 5 6 7 8 9 10 ... 15 16 17 >>